The new point-of-care biomarker test detects levels of a specific antibody (DRH1) to HPV16. The study shows a link between rising levels of these HPV antibodies and cancer.
Read More
The Lucira Covid-19 All-In-One Test Kit is a molecular (real-time loop mediated amplification reaction) single-use test that is intended to detect the novel coronavirus SARS-CoV-2 that causes covid-19.
Read More
This additional BARDA funding supports a test designed to read the immune system and rapidly diagnose acute infection at the point of care.
Read More
The contract enables InBios to ramp up production of the covid-19 tests to 400,000 units per week – 20 times the facility’s current output – by May 2021.
Read More
The BD Veritor Plus System has been authorized for use by Health Canada under an interim order.
Read More